1. Home
  2. TNON vs PMCB Comparison

TNON vs PMCB Comparison

Compare TNON & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.91

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

SELL

Current Price

$4.28

Market Cap

4.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TNON
PMCB
Founded
2012
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.0M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
TNON
PMCB
Price
$0.91
$4.28
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
95.4K
★ 169.4K
Earning Date
11-12-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.90
N/A
EPS
N/A
★ N/A
Revenue
★ $3,944,000.00
N/A
Revenue This Year
$44.38
N/A
Revenue Next Year
$39.49
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 20.35
N/A
52 Week Low
$0.96
$0.25
52 Week High
$40.95
$8.17

Technical Indicators

Market Signals
Indicator
TNON
PMCB
Relative Strength Index (RSI) 22.15 67.19
Support Level N/A $0.57
Resistance Level $4.18 $8.17
Average True Range (ATR) 0.17 0.37
MACD -0.02 0.42
Stochastic Oscillator 4.65 49.86

Price Performance

Historical Comparison
TNON
PMCB

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: